OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (17)

  1. Myungshin Kim. Cost-effective BRCA Testing in Advanced Ovarian Cancer. Ann Lab Med 2023;43:3
    https://doi.org/10.3343/alm.2023.43.1.3
  2. Jae Hee Lee, Do-Hoon Kim. Utility of Next-Generation Sequencing Panel Including Hereditary Breast and Ovarian Cancer-Related Genes for Pathogenic Variant Detection. Keimyung Med J 2024;43:44
    https://doi.org/10.46308/kmj.2023.00283
  3. Jong Eun Park, Min-Chae Kang, Taeheon Lee, Eun Hye Cho, Mi-Ae Jang, Dongju Won, Boyoung Park, Chang-Seok Ki, Sun-Young Kong. Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis. Cancers 2024;16:3318
    https://doi.org/10.3390/cancers16193318
  4. Malwina Suszynska, Piotr Kozlowski. Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations. Genes 2020;11:798
    https://doi.org/10.3390/genes11070798
  5. Kuenyoul Park, Min Kyu Kim, Taegeun Lee, Jinyoung Hong, Hyun‐Ki Kim, Sunyoung Ahn, Young‐Jae Lee, Jisun Kim, Shin‐Wha Lee, Jong Won Lee, Woochang Lee, Sail Chun, Byung Ho Son, Kyung Hae Jung, Yong‐Man Kim, Won‐Ki Min, Sei‐Hyun Ahn. Performance evaluation of an amplicon‐based next‐generation sequencing panel for BRCA1 and BRCA2 variant detection. Clinical Laboratory Analysis 2020;34
    https://doi.org/10.1002/jcla.23524
  6. Chang-Seok Ki. From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer. Ann Lab Med 2020;40:99
    https://doi.org/10.3343/alm.2020.40.2.99
  7. Y. Nakamura, S. Onodera, M. Takano, A. Katakura, T. Nomura, T. Azuma. Development of a targeted gene panel for the diagnosis of Gorlin syndrome. International Journal of Oral and Maxillofacial Surgery 2022;51:1431
    https://doi.org/10.1016/j.ijom.2022.03.054
  8. Priyanka Narayan, Muhammad Danyal Ahsan, Emily M. Webster, Luiza Perez, Sarah R. Levi, Benedict Harvey, Isabel Wolfe, Shanice Beaumont, Jesse T. Brewer, Drew Siegel, Charlene Thomas, Paul Christos, Andy Hickner, Eloise Chapman-Davis, Evelyn Cantillo, Kevin Holcomb, Ravi N. Sharaf, Melissa K. Frey. Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.. Gynecologic Oncology 2023;177:72
    https://doi.org/10.1016/j.ygyno.2023.07.017
  9. Shiori KANEKO, Takeshi INOUE, Hideki ISHIZU. A Case of Synchronous Bilateral Male Breast Cancer with a Family History of Male Breast Cancer. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 2020;81:1975
    https://doi.org/10.3919/jjsa.81.1975
  10. Fawz S. AlHarthi, Alya Qari, Alaa Edress, Malak Abedalthagafi. Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population. npj Genom. Med. 2020;5
    https://doi.org/10.1038/s41525-019-0110-y
  11. Jin‐Sun Ryu, Hye‐Young Lee, Eun Hae Cho, Kyong‐Ah Yoon, Min‐Kyeong Kim, Jungnam Joo, Eun‐Sook Lee, Han‐Sung Kang, Seeyoun Lee, Dong Ock Lee, Myong Cheol Lim, Sun‐Young Kong. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. Cancer Science 2020;111:3912
    https://doi.org/10.1111/cas.14600
  12. Kyoung Bo Kim, Sunggyun Park, Jung Sook Ha, Namhee Ryoo, Do-Hoon Kim. Three Cases of False-positive Multiplex Ligation-dependent Probe Amplification of BRCA1. Ann Lab Med 2022;42:497
    https://doi.org/10.3343/alm.2022.42.4.497
  13. P. Macquere, S. Orazio, F. Bonnet, N. Jones, V. Bubien, J. Chiron, D. Lafon, E. Barouk-Simonet, J. Tinat, L. Venat-Bouvet, P. Gesta, M. Longy, N. Sevenet. Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition. J Hum Genet 2022;67:339
    https://doi.org/10.1038/s10038-022-01014-3
  14. Rebeca Silveira Grasel, Paula Silva Felicio, André Escremim de Paula, Natalia Campacci, Felipe Antônio de Oliveira Garcia, Edilene Santos de Andrade, Adriane Feijó Evangelista, Gabriela Carvalho Fernandes, Cristina da Silva Sabato, Pedro De Marchi, Cristiano de Pádua Souza, Cláudia Alessandra Andrade de Paula, Giovana Tardin Torrezan, Henrique de Campos Reis Galvão, Dirce Maria Carraro, Edenir Inêz Palmero. Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients. Front. Oncol. 2020;10
    https://doi.org/10.3389/fonc.2020.571330
  15. Min-Chae Kang, R.N., Jong Eun Park, Mi-Ae Jang, Dongju Won, Boyoung Park, Seeyoun Lee, Dong Ock Lee, Kum Hei Ryu, Yoon-Jung Chang, Sun-Young Kong. Clinical Significance of PALB2 Pathogenic Germline Variant. Lab Med Online 2024;14:311
    https://doi.org/10.47429/lmo.2024.14.4.311
  16. Shenin A. Dettwyler, Erika S. Koeppe, Michelle F. Jacobs, Elena M. Stoffel. Outcomes of retesting in patients with previously uninformative cancer genetics evaluations. Familial Cancer 2022;21:375
    https://doi.org/10.1007/s10689-021-00276-8
  17. Jaehyeok Jang, Yoonjung Kim, Jae-Hoon Kim, Sun-Mi Cho, Kyung-A Lee. Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer. Ann Lab Med 2023;43:73
    https://doi.org/10.3343/alm.2023.43.1.73
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd